Corbus Pharmaceuticals (CRBP) PT Lowered to $53 at Oppenheimer
Tweet Send to a Friend
(Updated - September 30, 2025 8:05 AM EDT)
Oppenheimer analyst Jeff Jones lowered the price target on Corbus Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones lowered the price target on Corbus Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
